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Background: In Sub-Saharan Africa more than 270,000 women die from maternal deaths, 
worldwide approximately 76,000 women and 500,000 babies die yearly due to preeclampsia. It 
affects about 6-8 % of all pregnancies. (AbouZahr & Wardlaw 2001, 17; ACOG 2002, 2; WHO 
2007, 17-18.) Studies have shown that up to 77% women affected with preeclampsia lack 
knowledge about preeclampsia, and therefore cannot take preventative measures (East et al. 
2011, 1-6.) 
Objective: To increase the knowledge about preeclampsia to women with a high-risk pregnancy 
and to create a webpage in Terveysnetti. 
Methods: A literature review was carried out on how to create effective webpages that are 
viewed as trustworthy. Different aspects of a webpage increase the trustworthiness of the site. 
HON Code defines 8 principles that go to the trustworthiness: authoritative, complementarity, 
privacy, attribution, justifiability, transparency, financial disclosure and advertising Policy. 
Results: Basic information was transformed into webpages and uploaded to Terveysnetti. These 
webpages are available for women seeking knowledgeable advice regarding preeclampsia. 
Conclusion: Lack of adequate knowledge about preeclampsia was found to be a contributing 
factor to the high rate of maternal deaths. 
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1 INTRODUCTION 
Preeclampsia (PE) is defined as a serious complication of pregnancy. It is a 
multisystem disorder characterized by the onset of gestational hypertension 
(140/90 mm Hg or more, measured in two separate readings taken at least 6 
hours apart) and the presence of protein in the urine – proteinuria (defined as 
reading greater than 300 mg in a 24 hour urine collection; 1+ or more on 
dipstick testing or a protein: creatinine ratio ≥ 30 mg/mmol on a random 
sample.) Preeclampsia occurs after 20 weeks’ gestation. It may also occur up to 
six weeks after child birth (postpartum). Other organs of the body such as 
kidney and liver may be damaged. Pregnancy complications due to 
preeclampsia include low birth weight, pre-term birth and still births. PE may 
have further consequences to the mother. (Duley et al. 2001, 329; Milne et al. 
2005, 576; Duley et al. 2006, 463; Lloyd 2009, 398.) 
An estimated 536,000 maternal deaths occur annually. Of those, 270,000 occur 
in Sub-Saharan Africa. About 76,000 women and 500,000 babies die yearly 
worldwide due to PE. It is believed that preeclampsia affects approximately 6-
8% of all pregnancies, though the exact incidence rate remains unknown. 
(AbouZahr & Wardlaw 2001, 17; ACOG 2002, 2; WHO report 2005, 63). In 
Finland about 5% of all pregnant women are affected by preeclampsia 
(Terveyskirjasto 2009). 
This thesis is in twofold: the prevalence of preeclampsia globally and the affect 
it has on maternal deaths; and pregnant women’s knowledge about 
preeclampsia. Studies show that pregnant women lack adequate knowledge 
about preeclampsia (Oyira et al. 2009, 1-6; East et al. 2011, 1-5). This 
knowledge could potentially prevent pregnancy complications and prevent 
maternal deaths (Oyira et al. 2009, 1-6; East et al. 2011, 1-5). It is for these 
reasons that this topic was chosen, as to shed more light to the population who 
are affected by preeclampsia.  
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The task of this project is to create a webpage in Terveysnetti. The aim of the 
project is to increase knowledge about preeclampsia to the selected population. 
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2 PREECLAMPSIA DISORDER 
Preeclampsia falls into the category of hypertensive disorders (Lloyd 2009, 
398). Until the mid-1990s preeclampsia was a disease of first pregnancies, 
affecting most women’s first pregnancy (Robillard et al. 2007, 2). The 
pathophysiology of preeclampsia is still unknown. ‘Preeclampsia has been 
described as a disease of theories, because the cause is unknown.’ 
(DeCherney & Nathan 2003, 338; Sibai et al. 2005, 788; Zamorski 2008, 9.) The 
following is one of a couple theories for the causes of preeclampsia.  
2.1 Aetiology 
Development of preeclampsia is said to occur in two stages, with the placenta 
being the primary cause of hypertensive disorders. In normal development 
during the first stage in early pregnancy, the muscular walls and endothelium 
undergo changes (eroding of spiral arteries, which supply blood and nutrients to 
the placenta) to ensure an optimum environment for the developing blastocyst. 
The second phase is between weeks 16 and 20. Those changes that occurred 
during the first phase lead to dilated vessels that are incapable of 
vasoconstriction. This leaves the blood supply system to the uterus with low 
pressure and high blood flow resulting in maximum placental perfusion. In this 
theory it is believed that preeclampsia, inhibits the erosion of spiral arteries, 
therefore causing decreased placental perfusion. Decreased placental perfusion 
can lead to early placental hypoxia and oxidative stress. PE is difficult to 
clinically detect in the first stage. (Roberts et al. 2005, 1243-1244; Lloyd 2009, 
398-399.) Refer to Figure 1. 
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Figure 1.Two-stage model of the pathophysiology of preeclampsia  
(Roberts et al. 2005, 1244). 
 
During the second stage of preeclampsia, one factors leads to another. As 
mentioned before, decreased placental perfusion can lead to an oxidative state. 
The oxidatively stressed placenta triggers the release of one or more factors. 
This leads to damaged endothelial cells of the endothelium. Due to the maternal 
systemic inflammatory response to the endothelial dysfunction, clinical signs of 
preeclampsia become evident but only after the 20th week of gestation. (Roberts 
et al. 2005, 1243-1244; Lloyd 2009, 399.) 
Endothelial cells help to regulate capillary transport, the control of plasma lipid 
contact, modulate vascular smooth muscle in response to stimuli and 
synthesize prostacyclin and nitric oxide. Both prostacyclin and nitric oxide aid in 
vasodilation and prevent platelet accumulation. Therefore, inhibiting the 
formation of blood clots. Damaged endothelial cells resulting from the  
inflammatory response will lead to the following: reduced the production of 
prostacyclin and nitric oxide, which can lead to the formation of blood clots; 
increased production of thromboxane (Tx), a vasoconstrictor; increased 
vascular sensitivity to angiotensin II (controls blood pressure and helps with the 
excretion of salt and water) which activates coagulation cascade and triggers 
abnormal intravascular coagulation; and an increased oxidative stress. (Lloyd 
2009, 399; Shaker et al. 2011, 539-540.) 
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Figure 2. Pathophysiological Progression of Preeclampsia (Weissgerber 2004, 
2024-2031). 
 
Central Nervous System 
Auto-regulation is the process by which tissues are capable of regulating their 
own blood flow. The blood pressure may rise to a level at which auto-regulation 
is no longer able to function causing the blood-brain barrier to increase its 
permeability. This results in cerebral edema. Cerebral edema is seen in more 
patients with severe preeclampsia or eclampsia itself. Studies related to 
cerebral edema in preeclampsia are still inconclusive. (DeCherney & Nathan 
2003, 339-340; Lloyd 2009, 400.) 
Cardiovascular & Pulmonary System 
Hypertension combined with the endothelial cell damage affects capillary 
permeability. Plasma volume decreases because plasma proteins leak from the 
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damaged blood cells. It also causes hypovolemia and hemoconcentration. This 
is reflected in an elevated hematocrit level. The plasma that leaks from the 
damaged blood cells, increases edema within the extracellular space. Again this 
is just one theory as to the effects on the cardiovascular system. (DeCherney & 
Nathan 2003, 340-341; Lloyd 2009, 399-400.) 
In severe preeclampsia or eclampsia pulmonary edema may occur. It may be 
cardiogenic or non-cardiogenic. In these severe cases, lungs may become filled 
with fluid leading to less oxygenation and cyanosis. This complication may lead 
to death. (DeCherney & Nathan 2003, 340; Lloyd 2009, 399-400.) 
Blood 
In most patients with preeclampsia, clotting systems are normal. However, 
some patients have thrombocytopenia. Vasoconstriction and the dysfunctional 
endothelium go on to activate the coagulation cascade. It results from platelets 
being trapped in fibrin clots. The accumulation of these platelets causes 
thrombocytopenia. Disseminated intravascular coagulation (DIC) is 
characterized by low platelets, prolong prothrombin time and low fibrinogen 
levels. As fibrin levels increase and fibrin and platelets are deposited, the blood 
flow to many organs is reduced, especially to the kidneys, liver, brain and 
placenta. This condition can cause complications that can lead to hemorrhaging 
during birth. (Lloyd 2009, 400.) 
Kidneys & Liver 
Hypertension of the kidneys can lead to vasospasm resulting in decreased renal 
blood flow. The reduced blood flow can lead to hypoxia and edema of the 
endothelial cells of the glomerular capillaries. This glomeruloendotheliosis 
allows plasma proteins, in the form of albumin, to flow into the urine 
(proteinuria). As the condition worsens, oliguria develops, an increased serum 
creatinine, uric acid and reduce creatinine. Hypertension of the hepatic vascular 
bed also results in hypoxia and edema of the liver cells. This may lead to 
swelling of the liver and causes upper abdominal pain. This sign is indicative of 
preeclampsia. Liver function is reflected by a decrease albumin level and rise in 
liver enzyme levels. (Reynolds et al. 2003, 341; Lloyd 2009, 400.) 
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Signs & Symptoms 
Preeclampsia presents as hypertension associated with proteinuria. 
Hypertension is a blood pressure of over 140/90 mm Hg on at least two 
separate occasions, 6 hours apart. It can also be a significant increase in either 
the systolic or diastolic readings. (Sibai et al. 2005, 786; Lloyd 2009, 398.) The 
National High Blood Pressure Education Programme classifies proteinuria as ‘ 
1+ (300 mg/L or more) on dipstick testing, a protein: creatinine ratio of ≥ 30 
mg/mmol on a random sample, or a urine protein excretion of ≥ 300mg/24 
hours’ (see Lloyd 2009, 398). Preeclampsia can be diagnosed without the onset 
of proteinuria with the following symptoms: severe headaches, blurred vision, 
upper abdominal pain, and/or altered biochemistry. These include raised urates, 
low platelet counts and abnormal liver enzyme levels. (Murray et al. 2002, 279; 
Lloyd 2009, 398; Zamorski et al. 2001, 263-264.)  
Affects to the Mother &  Fetus 
Severe PE may lead to the development of a more complicated and serious 
condition of HELLP or DIC. The mother has a greater risk of hemorrhaging 
during birth and postpartum. This is because of the potential blood disorders 
associated with PE. PE can also affect the mother’s heart, brain, liver, kidneys 
and eyes. Studies have shown that women who suffered from PE are at an 
increased risk of developing cancer and cardiovascular conditions later in life. In 
more severe cases of PE a stroke or even death may occur. (Sibai et al. 2005, 
785-786; Bellamy et al. 2007, 974.) 
The fetus is also susceptible to complications resulting from PE. Most common 
is preterm birth, before 37 weeks gestation. In conjunction with preterm birth, 
many babies have a low birth weight. Other complications include respiratory 
distress syndrome and growth retardation. In more serious cases of PE, 
placental abruption (the separation of the placenta from the uterus) or even 
death may occur (still birth). (Sibai et al. 2005, 786; Bellamy et al. 2007, 974.) 
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2.2 Global burden of hypertensive disorders & mortality 
Maternal death as defined by the International Statistical Classification of 
Disease Maternal death as defined by the International Statistical Classification 
of Disease and Related Health Problems, Tenth Edition,  
‘The death of a woman while pregnant or within 42 days of termination of 
pregnancy, irrespective of the duration and site of the pregnancy, from 
any cause related to or aggravated by the pregnancy or its management 
but not from accidental or incidental causes’ (ICD-10). 
 
Maternal deaths can occur from either direct or indirect causes. Direct causes 
obstetric deaths would be from complications of the pregnant state. For 
example this includes hemorrhage, preeclampsia or cesarean sections. Indirect 
obstetric deaths would be deaths that occurred due to an existing disease or 
were accelerated due to the pregnant states. This might include existing cardiac 
conditions or renal disease. (WHO 2007, 4.) 
 
According to the WHO (2007, 4) there are two factors affecting maternal deaths. 
The first is the risk of mortality in conjunction with a single pregnancy or a single 
live birth, and the second being, the number of pregnancies or births that are 
experienced by women of child-bearing age. The MMR (maternal mortality ratio) 
is defined as the number of maternal deaths in a population during a given time 
period per 100,000 live births during the same time-period. The MMR shows the 
risk of maternal death that is relative to the number of live births. In comparison, 
the MMRate is defined as the number of maternal deaths in a populations 
during a given period per 100,000 women of reproductive age during the same 
time-period. The MMRate shows deaths per pregnancy and per birth. The adult 
lifetime risk of maternal mortality for women can also be calculated from the 
MMR and MMRate. Refer to Table 1.  (WHO 2007, 4-5.) 
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Table 1. Definitions  
 
In 2005 of the estimated 536,000 maternal deaths, 533,000 (99%) occurred in 
developing countries. Of these 270,000, more than half, occurred in Sub-
Saharan Africa. The MMR as defined by the United Nations MDG was the 
highest (920) in SSA in 1990 and dropped to 900 in 2005. However the 
maternal deaths in 1990 were 212,000 compared to the 270,000 in 2005.Other 
statistics by the United Nations MDG include a life time risk of maternal death 
(1:x) of 1: 22 in the SSA in 2005. (WHO 2007, 17-18.) All of the figures from 
1990 and 2005 are shown in Table 2. and Table 3.   
 
Table 2. MMR and # of Maternal Deaths in 1990 and 2005 (WHO 2007, 35-38). 
Comparison 
by  
1990 2005 
 MMR # of 
Maternal 
deaths 
MMR # of 
Maternal 
deaths 
UNICEF 940 206 000 920 265 000 
UNFPA 940 204 000 920 260 000 
The World 
Bank 
920 212 000 900 270 000 
UN MDG 920 212 000 920  270 000 
 
 
 
Maternal mortality ratio # of maternal deaths during a given time- period 
100 000 live births during the same time-period 
Maternal mortality rate  # of maternal deaths in a given period 
100 000 women of reproductive age during the same 
time-period 
Adult life time risk of 
maternal death 
The probability of dying from a maternal cause during a 
woman’s child-bearing years 
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Table 3.Lifetime Risk of Maternal Death (WHO 2007, 35-38). 
Organization  MMR # of Maternal 
Deaths  
Lifetime risk 
of maternal 
death 1: 
UNICEF  920 265 000 22 
UNFPA 920 260 000 22 
The World Bank 900  270 000  22 
 UN MDG 920 270 000 22 
 
The WHO commissioned evidence and information about the global burden of 
hypertensive disorders in 2000 by Dolea & AbouZahr (2003, 4). They stated 
that there are several risk factors that contribute to preeclampsia/eclampsia. 
The factors include-type 1 diabetes, gestational diabetes, twin birth, obesity, 
previous miscarriage and longer intervals between pregnancies. (Dolea & 
AbouZahr 2003, 4.) 
The WHO divided the regions into categories. Of the five sub-categories, two 
are within the SSA region. These two regions both had a PE incidence rate of 
2.8% of all births. Unfortunately these results are not exact. These incidents 
were recorded from hospitals where many births occur outside the hospital. 
Despite the fact that the GBD in Dolea & AbouZahr (2003, 4-7) put 
preeclampsia and eclapsia together, the total case fatality was still 0.1% to 
4.0% with an overall mortality of 14% of all maternal deaths. 
Preeclampsia/eclampsia account for about 50% of all hypertensive disorders. 
Since elcampsia can occur without the onset of seizures, and coupled with the 
lack of resources to detect preeclampsia, reporting can only be estimated. 
(Dolea & AbouZahr 2003, 4-7.)  
South Africa 
The WHO launched the Safe Motherhood Initiative at a global conference in 
1987 in Nairobi, Kenya. The goal of this initiative brought light to the immense 
differences in MMRs between developed and developing countries. It was 
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because of this initiative that South Africa was the first to adopt an ongoing 
National Audit and Confidential Enquiries into Maternal Deaths. Unfortunately, 
like many other developing countries, accurate reporting was difficult since data 
collection for a part of the MMR was inaccurate (live births or deliveries). 
(Fawcus et al. 2005, 1257-1258.) 
 
One of the participating hospitals was the Peninsula Maternal and Neonatal 
Service (PMNS) in Cape Town. The maternal services were comprised of 
Midwife Obstetric Units (MOUs), secondary hospital and a tertiary unit. A 50-
year audit was collected from 1953-2002 and compiled to compare trends in 
rates and causes of deaths. The years were put into three triennias (2954-1956, 
1981-1983 and 1999-2001). (Fawcus et al. 2005, 1257-1258.)  
 
The  MMR (as seen in Table 4.) in 1954-1956 was significantly higher than the 
other two triennias. Fawcus et al. (2005, 1261-1262) believes that the decline 
from 1953-1985 was due to a couple of reasons. One reasons might be due to 
that during that time period PMNS switched to MOUs from a previous primarily 
midwifery run establishment. Also during this time an ambulance committed 
specifically for obstetric and neonatal emergencies was set into place. This 
primarily reduced the decline in deaths due to hemorrhaging. As knowledge 
progressed about hypertensive disorders affecting women, so did the critical 
care. This too contributed to the overall decline in hypertensive disorders. 
(Fawcus et al. 2005, 1261-1262.) 
 
Table 4. Breakdown of MMR in 1954-1956, 1981-1983 & 1999-2001 
Causes 1954-1956 1981-1983 1999-2001 
 # of 
deaths 
MMR # of 
deaths 
MMR # of 
deaths 
MMR 
Direct 
Hypertensive 
disorders 
19 80.4 8 11.3 12 14.5 
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Causes 1954-1956 1981-1983 1999-2001 
 # of 
deaths 
MMR # of 
deaths 
MMR # of 
deaths 
MMR 
Hemorrhage 12 50.8 3 4.2 3 3.6 
Suspected 
pulmonary 
embolism 
6 25.4 2 2.8 3 3.6 
       
 
While the methods of reporting and collecting data remained the same during 
the span of the research, the area in which PMNS served was greatly 
increased. Therefore it can be concluded that one of the denominators, that 
ultimately affected the MMR, may have inaccurately affected the MMR, 
exaggerating it, for that time period. On the other hand, if the effects on the 
MMR decline were due to the increase in women served, it would then have 
had a more equal decline effect to all of the MMR categories. Therefore, one 
would then have to believe there was a significant decline in the MMR. For this 
reasons, one needs to look at the other two triennas for more stable 
information. (Fawcus et al 2005, 1260-1262.)  
 
In 1981-1983, the MMR for hypertensive disorders was 11.3 but rose to 14.5 in 
1999-2001. Also during the same time periods, suspicion of pulmonary 
embolism increased from 2.8 to 3.6. While the MMRs for those two causes 
increased, the MMR for hemorrhage decreased from 4.2 to 3.6. As previously 
mentioned before, a special ambulance system was set into place specifically 
for obstetric and neonatal emergencies. (Fawcus et al. 2005, 1260-1262.) 
 
Of the total deaths during 1954-1956, hypertensive disorders accounted for 
about one third (19/ 60). During 1981-1983, one fourth (8/32) of the recorded 
deaths were due to hypertensive disorders. However during the last triennia, 
only 23% (12/52) of the deaths were attributed to HD. Between the 1981-1983 
and 1999-2001 the overall MMR from hypertensive disorders increased, while 
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the overall percentage of deaths by hypertensive disorders decreased. The 
epidemic of HIV/AIDS-related deaths increased during these two triennias. 
Despite the increase in HIV/AIDS-related deaths, one could argue both sides as 
to why this number could have increased or decreased. First of all, as 
technology advanced during these times and became available to South Africa, 
one would be led to conclude that deaths from hypertensive disorders would 
have increased. On the other hand, the MMR could have decreased as more 
knowledge about preeclampsia came to light, even though resources to 
manage hypertensive disorders were and are not available. (Fawcus et al. 
2005, 1260-1262.) 
Zambia 
Zambia has one of the higher MMRs in SSA, and it also has one of the highest 
perinatal and infant mortality rates.  A study was carried out in four rural area 
communities in Zambia to determine the causes of stillbirths, neonatal deaths 
and early childhood death. Information was collected verbally door to door. 
Areas were chosen at random, then every third house was selected and 
assessed for eligibility. After the information was collected by the auditors, each 
case was then reviewed by three pediatricians as to contributing factors for the 
death. (Turnball et al 2011, 894.) 
The data showed only one stillborn death directly related to preeclampsia. This 
roughly accounts for only two percent of the stillborn deaths. However, after 
review by the pediatricians, 11% of the stillbirths could be contributed to 
maternal hypertension/pre-eclampsia. There were no deaths of a neonatal due 
to direct contributing factors of a hypertensive disorder 
Zimbabwe 
As previously stated, exact numbers of the effects of preeclampsia are not 
precise, but research has shown that specific factors influence the outcomes. 
Mudokwenuy-Rawdon et al. (2003, 40) points out that in developing countries 
about 1 in every 100 deliveries is complicated by preeclampsia/eclampsia. In 
Zimbabwe at Mpilo Central Referral Hospital (MCRH) about 20.7 % of obstetric 
deaths were due to severe preeclampsia/ eclampsia. For these reasons, 
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investigating factors contributing to maternal deaths from severe 
preeclampsia/eclapmsia would additionally address contributing factors in other 
causes of maternal death, and ultimately helping to reduce the overall maternal 
mortality. It should be noted that the final cause of death due to hypertension in 
pregnancy was due to intracranial hemorrhage (stroke), rupture of the liver and 
post-partum hemorrhage in South Africa at the time of the study. (Mudokwenuy-
Rawdon et al. 2003, 40-41.)  
In the retrospective study, Mudokwenuy-Rawdon et al. (2003, 41) set out to find 
if there are any difference in factors physiologically between those patients that 
survived (control) and those that died (cases), and if there any difference in care 
received by the surviving (control) and the non-surviving (cases). For every 
case (a woman who died from severe preeclampsia/ eclampsia), two controls 
(women who survived) were also selected. Files were collected from January 1, 
1995 to December 31, 1997, in Bulawayo, Zimbabwe. In total there were 21 
cases and 42 controls. During this time, overall statistics of the hospital were 
such: 89% of the maternal deaths were due to obstetric complications, of that 
about 20% were due to severe preeclampsia/ eclampsia; and the MMR was 407 
in 1995 and 275 in 1997. (Mudokwenuy-Rawdon et al. 2003, 44-46.) 
Physiological factors such as anemia and blood pressure were not a physiologic 
indicator that a patient would have a greater risk for mortality, since findings 
were contradictory. It was confirmed that that gravidity was a contributing factor 
to preeclampsia. The most affected group in both cases and controls was 
primigravida and gravid ≥ 4. However, there was no significant difference 
between the two groups to suggest it would or wouldn’t lead to death. Both 
cases and controls received C-sections (90% cases and 93% controls). These 
results suggest a high rate of patients presenting with PE or eclampsia undergo 
C-sections. However no there was no significant difference between the two 
groups. (Mudokwenuy-Rawdon et al. 2003, 46-51.) 
Care rendered for controls and cases were in such context of positive and 
negative, a yes or no style. Areas that were analyzed were: antenatal care 
(booked or unbooked) and emergency care ( monitoring BP, temperature, 
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respiration, pulse, antihypertensive/ anticonvulsant drug treatment, fluid intake 
and output recording, follow-up care, type of care and type of documentation. 
The analysis showed that being booked had no bearing on whether a woman 
lived or did not (13/21 cases booked). Emergency care was received by 17/21 
cases and 23/42 controls. These findings are paradoxical, suggesting women 
who received emergency care were more likely to die. The results are possibly 
due to the fact that better records were kept for a dying or dead patient with the 
expectation of an audit. Follow-up care (15/21 cases and 12/42 controls) 
suggests that women who received follow-up care had less chances of living 
that those who did not receive follow-up care. However, controls receiving 
follow-up care may not have been as well kept as the cases. (Mudokwenuy-
Rawdon et al. 2003, 48-51.) 
Overall, Mudokwenuy-Rawdon et al. (2003, 53-55) was able to conclude that 
more care was taken of women’s records who passed or who were more ill, 
than those who survived or had a greater chance of surviving. These results 
were thought to be due to the potential audit of maternal deaths. More 
information is needed in order to potentially apply these findings to a greater 
population. (Mudokwenuy-Rawdon et al. 2003, 48-55.) 
Response 
Fawcus et al. (2005, 1261-1263) points out there are many limitations to their 
study. Unfortunately in an audit, the records of care may or may not have been 
accurate, even though data collection methods remained the same over the 50-
year period.  During the audit, in 1983, there was an increase in the area served 
by PMNS. Also, Fawcus et al. (2005, 1262) mentions the ‘denominator effect’, 
suggesting that the MMR may have been exaggerated as more low-risk women 
were giving birth in a health care facility in 1981-1983 as compared to in 1954-
1956.  
The research done by Turnbull et al. (2011) has a few limitations and leading 
one to question the reliability of the findings. Though the population surveyed 
was large, the collection method was verbally given from the families who lost a 
child. The verbal autopsy assessment was only based upon what the families 
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mentioned or believed to be contributing factors. Therefore, the three 
pediatricians assigning the cause and factors of death could only go upon the 
information given to them by the surveyors. Families may or may not have been 
able to present all contributing factors, due to their level of knowledge and 
socio-economic background, and may not have understood information given to 
them at the time of the child’s death. In addition, many women gave birth at 
home without an attendant or just a nurse/mid-wife.  Therefore, causes of death 
cannot be obtained. In such communities where the survey took place, religious 
groups with specific beliefs may not have contributed accurate information 
regarding the events surrounding the child’s death. This article is the perfect 
example of specifically pinpointing deaths to preeclampsia. Like mentioned in 
the article, there was no accuracy with the information they received from the 
families that were surveyed. The doctors’ contributing factors could only be as 
good as the information received. No neonatal deaths were directly linked to 
preeclampsia. However, a common side effect of PE is prematurity. Therefore, 
one would be able to argue that some of the neonatal deaths due to prematurity 
could be linked to preeclampsia. Despite the previously mentioned limitations, 
and the lack of autopsy availability, this research calls for investigations into 
childhood mortality and the promotions of public health programs.  
In Muduokwenuy-Rawdon et al. (2003) the limitation for this research was the 
fact that the data was collected from only one hospital and the results cannot be 
generalized. Unfortunately, the records kept by the hospital, for both the cases 
and controls, were not unilaterally equal. Therefore, findings based on the data 
may be distorted since the records were not complete for all women. As 
Muduokwenuy-Rawdon et al. (2003, 54) suggests, more information could have 
been obtained through observing and comparing care rendered. Overall more 
research is needed because paradoxical results are possibly due to incomplete 
records of cases and controls.  
In regards to MMRs and MMRates, one needs to keep in mind that these 
numbers are only estimates. Many women give birth in a village or outside of a 
medical facility, and not all of those deaths are recorded. In developing areas, 
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such as in the SSA, local hospitals lack the resources to provide a diagnosis for 
conditions such as PE. With more estimates, comes more reliability as to the 
global burden of hypertensive disorders of pregnant women.  
2.3 Women’s knowledge about preeclampsia 
East et al. (2011,1) carried out surveys on women’s experiences of 
preeclampsia and the results were 68 women (61% response rate) and 64 
(57%) partners, close relatives or friends. Respondents experiencing 
preeclampsia (n=53), eclampsia (n=5) and HELLP syndrome (n=26). In the 
surveys, 77% women reported lacking knowledge of preeclampsia preceding 
diagnosis, and after diagnosis, 50% did not appreciate the seriousness of their 
condition. Access to knowledge about preeclampsia was very important to 
women, their partners, relatives or friends (East et al. 2011, 1-4). It was stated 
that, although numerous sites can now be accessed with a simple online 
search, the quality and readability of information needs to be appropriate for 
women with varying levels of health literacy (East et al. 2011, 5). 
Oyira et al. (2009, 1) carried out a study to find out the knowledge, attitude and 
preventive practices towards preeclampsia among pregnant women. The 
research was based on pregnant women’s knowledge and their attitude about 
preeclampsia. The population involved 200 pregnant women and a sample of 
100 pregnant women was used for the study. (Oyira et al. 2009, 1.) Calder and 
Dunlop (1993, 33) had found that maternal deaths could be prevented if women 
were able to have adequate knowledge and positive attitude towards attending 
antenatal clinics while living local practices of juju (see Oyira et al. 2009, 1).  
Souza et al. (2007, 1) conducted a qualitative study using focus group 
techniques involving 28 women to analyze their maternal experience of 
preeclampsia in pregnancy. The results of the study showed that there was lack 
of knowledge with regard to preeclampsia and its association with premature 
births (Souza et al. 2007, 1). Quality of information provided to the women 
about pregnancy with preeclampsia during prenatal care was inadequate or not 
appropriate to their level of understanding (Souza et al. 2007, 5). 
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Included studies recruited a total of 240 pregnant women with PE. All women 
recruited were based on their knowledge about PE. A descriptive study by Oyira 
et al. (2009) indicated that maternal mortality was to due inadequate knowledge 
by pregnant women about PE. In a cohort study carried out by East et al. (2011, 
2) showed that out of 112 pregnant women recruited for the study, 77% had no 
knowledge of PE prior to diagnosis. Once diagnosed 50% of women did not 
appreciate how serious PE was because of lack of sufficient knowledge on the 
disorder. In the study, women wanted to access to information about PE. (East 
et al. 2011, 4.) See Table 5. 
Table 5. Pregnant Women’s Knowledge (Souza et al. 2007,3 ; Oyira et al. 
2009,3-4 ; East et al. 2011,3-4 ). 
 East et al. 
(2011)  
(n=112) 
Oyira et al. (2009)  
(n=100) 
Souza et al. (2007)  
(n=28) 
Women with no 
knowledge about PE 
77% 36% 71% 
Women who attended 
prenatal clinic  
- 80% 60% 
 
Preterm birth due to 
PE 
85% - 57% 
Perinatal death due to 
PE 
26.5% - 86% 
 
Souza et al. (2007, 2-6) conducted a study using focus group which involved 28 
pregnant women. Pregnant women included in the study had PE during 
pregnancy and preterm delivery. The study showed that the subject’s had lack 
of knowledge about PE and its association with premature births. In the study, 
20 women (71%) said they were not aware of PE during prenatal care. They 
were aware only after hospitalization and preterm delivery. (Souza et al. 2007, 
2-6.)  
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Response 
It was observed that the populations used in the studies regarding women’s 
knowledge about PE were too small to make any larger generalizations. 
However, their findings were clear that women lacked adequate knowledge 
about PE. In East et al. (2011, 1) the sample size was 112 people who had 
experienced PE, belonging to the consumer group of Australian Action on Pre-
Eclampsia (AAPE). Though the sample size was small, a staggering number of 
women (77%) had no previous knowledge of PE. Half (50%) of the women after 
diagnosis did not appreciate the seriousness of their condition, thus they did not 
seek preventive measures. The women belonging to AAPE may not represent 
all women experiencing PE. For this reason more research with a larger sample 
size is needed. 
In Oyira et al. (2009) the sample size was 100 women who had experienced PE 
in a general hospital- Calabar, Cross River State, Nigeria. The research 
questions were clearly defined: the level of pregnant women’s knowledge, and 
their attitude and beliefs about PIH. The questions were clearly answered thus 
providing recommendations for further intensive education for pregnant women 
regarding PIH. It also opens way for more research to confirm their findings. All 
Health personnel should be equipped and ready to provide information about 
PIH to pregnant women visiting prenatal clinics. Moreover, the concern for 
significant number of maternal deaths associated with PIH is prominent on 
global health agendas. 
Both East et al. (2011, 1-6) and Souza et al. (2007, 5) noted that the quality of 
information given to pregnant women with PE during prenatal care was not to 
their level of understanding so as to take preventative measures. Souza et al. 
(2007, 6) suggests that early diagnostic measures were essential for pregnant 
women who are at risk of PE. This was clearly shown in the study they carried 
out using focus group techniques involving 28 women in a facility specialized in 
high-risk pregnancies in Brazil.  Communication flaws between the health 
professionals and the pregnant women experiencing PE were noted, and this 
may have contributed to insufficient knowledge the women received.  
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3 PURPOSE & AIMS 
The task of this project is to create a webpage in Terveysnetti. The aim of the 
project is to increase knowledge about preeclampsia to the selected population. 
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4 METHODS 
A webpage is a document connected to the World Wide Web. It can be viewed 
by people who have a web browser and are connected to the internet. A 
webpage consists of a Hypertext Markup Language (HTML) file and any related 
files for scripts and graphics, and often hyperlinked to other documents on the 
Web. People search webpages on the internet for varying types of information.  
Recently, there has been an increase in numbers of online resources that offer 
health-related information and people are increasingly using the web for 
consumer health research. It is suggested that people searching for information 
on webpages via online means, view internet as a kind “human intermediary” 
that replaces the role used to be occupied by the librarians and other search 
mediators. (Chern Li Liew 2011, 621.)   
Apart from advice and health-related information, people also use webpages to 
be better informed, better prepared when meeting with the doctor, or for 
searching for support, alternative answers or reassurance. Time limitation in the 
consulting room between the doctor and the patient has led to more usage of 
online resources. (Sillence et al. 2006, 698.) According to Klein & Wilson (2003) 
Websites are more appealing to people who seek advice on important but 
sensitive matters (see Sillence et al. 2006, 698). Most people using webpages, 
who posted online for health advice, believe that it will enable them better deal 
with their health. However, assessing the quality of online information is an 
alarming task. (Silence et al. 2006, 698.) 
In the technology-based world one is able to research most anything online. 
According to Fox & Fallows (2003) reports show that 80% of adult internet users 
have gone online of general health information (see Silence et al. 2006, 698). 
Silence et al. (2006, 699) identified different trust factors, and the process in 
which a person analyses the source in which they are looking to for information.  
Eysenback et al. (2003) indicates that when it comes to assessing the quality of 
a website, the criteria includes accuracy, completeness and readability (see 
Silence et al. 2006, 698-699). ‘Accuracy referred to the degree of concordance 
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of the information provided with the best evidence or with generally accepted 
medical practice. Completeness was calculated as the proportion of a priori-
defined elements covered by the website. Readability formulas were also used 
to establish the reading level of a document.’ (See Silence et al. 2006, 698.) 
Silence et al. (2006, 699) has also defined various factors in which most likely 
govern how individuals feel about the trustworthiness of a website. First is the 
look and feel of the site. The sites that rated high were ones with visual appeal, 
and the sites that were mistrusted were ones with poor visual design. Second, 
the branding of the site e.g. trusted or familiar logos influenced individuals. 
Thirdly, individuals were influenced by the perceived quality of the website. 
Lastly, individuals were influenced by the personalization of the website, and if it 
directly pertains to them. (Silence et al. 2006, 699-700.) 
A model of trust has been created (see Figure 3.). There are three stages in the 
framework of trust: heuristic analysis, content evaluation and longer term 
engagement. Heuristic analysis refers to the look and feel of the site and the 
fundamental design. The following are included in heuristic analysis. Visual 
appeal: refers to the balance between text and graphics, in relation to the time it 
takes to load the site. Layout/ navigation: is vital when making a first 
impression. A site should have simple menu bars making it easy to quickly start 
navigating. Social identity: includes the use of appropriate graphics, mission 
statements and language pertaining to them.  Adverts: carefully should be 
carefully used. Too many can be distracting, but they also convey the extent at 
which the site is commercialized. Branding: provokes the user with a sense of 
familiarity. This includes colour, name and logo. (Silence et al. 2006, 701-702.) 
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Figure 3. Staged Model of Trust (Silence et al. 2006, 701). 
 
Systematic evaluation of the site content refers to more detailed and in-depth 
compared to the first stage. Language style and tone: websites with lots of 
medical terms can be difficult to read and understand for users who may have a 
newly diagnosis. However, for some users, medical terminology is completely 
appropriate. Site purpose: what the site is for. Content level: should be aimed 
towards the intended reader. Variation in depth should be considered, from a 
beginners search to a more in-depth knowledge. Source knowledge: the 
author’s knowledge or expertise is that of a medical professional or patient. 
Cross-referencing refers to the links made available to other websites. This 
allows the user to do more research and promotes a sense of openness. 
(Silence et al. 2006, 702-703.) 
Longer-term engagement refers to the long-term use the. Personalized content: 
content in which can be personalized, usually in the form of registration or 
creating a profile. Interactivity: the site engages the user. This can be done by 
quizzes, tools, emails and text updates. Updated content: Keep the users 
coming back for more information to keep updated. This aspect ensures that the 
user will look to the website in longer-term for consultation. User-generated 
content: helps to ensure longer-term engagement by allowing the users to 
contribute to the content on the website. (Silence et al. 2006, 703-705.) 
In another study conducted by Silence et al. (2007, 1853-1856), time spent on 
different websites and the factors which contributed to each site were roughly 
Rapid screening of 
sites based upon 
heuristic analysis 
Systematic 
evaluation of 
site content 
Integration of 
information 
across sites and 
sources 
Longer term 
consultation and 
self-disclosure 
processes 
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determined. In the first two minutes users sift through sites very quickly. (See 
Chart 1.)  Factors which contributed to the rejection or mistrust of a website 
were design factors: inappropriate name for the website, complex/ busty layout, 
lack of navigation aids, boring web design especially use of colour, pop up 
adverts, slow introductions to site, small print, too much text, corporate look and 
feel, poor search facilities, and content factors: irrelevant material and 
inappropriate material. Factors which contributed to the selection and trust of a 
site were design factors: clear layout, good navigation aids, interactive features 
e.g. assessment tools; and content factors: informative content, relevant 
illustrations, wide variety of topics covered, unbiased information, age specific 
information, clear simple language used, discussion groups and frequently 
asked questions section. (Silence et al. 2007, 1853-1858.) 
HON Code (Health On the Net) is a code of conduct for medical and nursing 
information that is published on the internet. The HON Code includes 8 
principles: Authorities, the qualifications of the authors; Complementarity, 
should enhance but not replace the doctor-patient relationship; Privacy, protects 
any personal information about the user; Attribution, sourcing all sites with dates 
and authors; Justifiability, justifies the sites benefits and performance; 
Transparency, allows the user accessibility and the correct contact information; 
Financial Disclosure, discloses any financial backing; and Advertising Policy, 
distinguishes the difference between the views of the site and ad content. All 8 
of these areas go to the trustworthiness of a website. (HON Code 1997). 
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Chart 1. Time Spent on Websites (Silence et al. 2007, 1857). 
 
  
0
2
4
6
8
10
12
11-30 seconds 31-60 seconds 1-2 minutes
Portal Site
Other (irrelevant, sales,
broken-links)
Relevant site
30 
 
TURKU UNIVERSITY OF APPLIED SCIENCES THESIS | Teonna Heintz & Emily Tirkkonen 
5 IMPLICATION OF PROJECT 
The topic of this thesis was chosen for personal reasons, because both authors 
have experienced the effects of preeclampsia. As sources have stated, PE is a 
manageable condition if women have adequate knowledge about the disorder 
(Lloyd 2009, 402-403). With this information, and the WHO’s findings that 
thousands of women and infants are effected by PE, makes this a relevant 
topic. It also indicates more attention should be alerted to this global problem. 
Articles were searched and retrieved from reputable sources and databases like 
EBSCO (Cihahl), Medline/Pubmed Central, Medwell journals. The search terms 
included preeclampsia, pre-eclapsia, toxemia, gestational hypertension, 
pregnant women, gravidity, risk pregnancy, knowledge, education, awareness, 
experience, attitude. The search strategy yielded text articles which were 
relevant to our research questions were included. Titles and abstracts which 
were irrelevant or with no further reading were excluded. Inclusion criteria were 
pregnant women, all stages of preeclampsia, gestational hypertension, 
treatment history, studies written in English language, study type which included 
literature reviews, policy documents and book reviews. Exclusion criteria were 
studies focusing only on hypertension, eclampsia, HELLP syndrome, and 
studies not written in English language. Data was independently extracted from 
the included studies. 
Literature reviews were used in this study to focus on the research topic and 
make critical analysis between different existing reviews that are related to our 
study. Individually we searched previous literature focusing on research 
questions. We peer reviewed the literature researches. Peer review helped to 
increase the validity of included articles (Polit et al, 2001, 305; Booth et al. 
2004, 105.) 
The commissioning of this project was from Aluesairaala, Salo city. See 
Appendix 1 and Appendix 2. 
Creation of the webpages was done in two sections: content and design. The 
content depth was based upon the targeted population and providing the basic 
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knowledge to the women experiencing PE. Contents were collected from 
different sources and complied to create a working webpage. Language used in 
the webpages was English, and terms were simple and understandable. All 
scientific terms were place in parenthesis. See Appendix 4. 
Layout was based upon Silence et al. (2006, 701-702) research identifying easy 
navigation as a factor affecting user in their decision to consult the webpage or 
move on to another. The headings are divided into 8 headings with 
subheadings once clicked on. Of the 8 headings, one is frequently asked 
questions. This is another factor that increases the trustworthiness of the 
webpage (Silence et al. 2006, 703-705).  
The colour purple was chosen for aesthetic reasons, feminine appeal, and it 
was used to contrast main headings and subheadings. Text font is Arial Narrow 
size 17/ 18. The font was chosen as it is a basic font and is readable on all 
devices. It will not be distorted, and the font size is easy to read. Pictures were 
purchased from istockphoto.com. See Appendix 3.  
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6 DISCUSSION 
The underlying theme of our thesis was that women are dying from a 
manageable pregnancy complication that could be prevented if they had 
adequate knowledge to take preventative measures. These webpages will be 
used to provide the basic knowledge about preeclampsia to pregnant women 
and/or their spouses, relatives and close friends. As stated before, many people 
search webpages on the internet for varying types of information, and 80% of 
adult internet users have gone online for general health information (Silence et 
al. 2006, 698.) It was thought that the population affected by preeclampsia 
especially newly diagnosed pregnant women, would access this information 
online and help them to take preventive measures against the disorder. 
Preeclampsia can only be managed when the affected women are able to 
access to the trusted health information posted online. The language used in 
the webpages was simple and understandable English to convey information 
about preeclampsia to the user’s level of understanding. Any scientific term 
used, an explanation was given in brackets for easy understanding. 
The reason for using the webpages in this thesis was to reach out to as many 
women affected with preeclampsia as possible. Informative materials were 
gathered from different reliable sources to create the webpages. However, the 
information provided in the webpages should be used by the targeted 
population for support and to be better informed when meeting with their 
physician. It should not replace the patient-physician role as seen in the Hon 
code principles. The webpages were presented to the commissioner at 
Neovula. The nurses liked the ease of the webpage and found the content to 
appropriate for the intended population. They suggested that under the FAQ 
section that the question ‘Why do I have to give so many urine samples and 
blood pressure readings?’ The suggested question has since been added to the 
webpage. In addition the nurses suggested that these webpages be updated as 
they will be used quite frequently.  
The webpages address the 8 principles of the HON Code. Authoritative: there is 
an Authors page, addressing the qualifications of the authors. Complementarity: 
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these pages prepare the patient for further meeting with their doctor and 
enhance the doctor-patient relationship. Privacy: user’s information is not used 
on the webpages. Attribution: all sites have been sourced on the references 
page. Justifiability: users are able to act accordingly in regards to PE from the 
knowledge they received from the webpages. Transparency: no direct contact 
information has been provided; only advice to contact your local neovula. 
Financial disclosure: commissioning of the webpages has been addressed 
under Authors. Advertising: there are no adverts on the webpages.  
The overall reliability of our thesis can be justified. In the project plan, inclusion 
and exclusion criteria’s were clearly defined. Multiple databases were searched 
for articles which made the search more extensive. However, there is a 
possibility some articles dealing with the topic could not be identified during the 
search. Since the search was limited to English language articles and journals, 
other useful articles dealing with the topic in other languages could not be 
captured. After researching the topic more, some overall topics needed to be re-
included: hypertensive disorders/ eclampsia. Unfortunately in many of the 
statistics and researches, preeclampsia was lumped in with hypertensive 
disorders overall and/or with eclampsia.  Each of the articles was peer reviewed 
for quality as was each portion of the thesis.  
 
Further Direction 
Many studies have been done regarding the prevalence of preeclampsia, the 
affect it has on maternal deaths and pregnant women’s knowledge about 
preeclampsia. There is still a big question mark remaining about the disorder. 
Future research should be done to expand the understanding on what pregnant 
women should know about PE, their level of understanding and aim to reduce 
the prevalence of the disorder that is associated with high maternal deaths. 
Finally, there is an urgent need for a study that involves large number of 
pregnant women experiencing preeclampsia to test their knowledge and level of 
understanding about the disorder. This will help to guide prevention education 
of preeclampsia which is associated with a high rate of maternal deaths. 
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The United Nations have created Millennium Development Goals with a target 
year of  2015. These goals included are divided into two areas: reduction of the 
MMR by three quarters and to achieve universal access to reproductive health. 
The reduction of the MMR will be achieved by the  reduction of maternal deaths, 
since many can be avoided. It will focus mainly on Southern Asia, SSA, areas 
that are known to carry a higher risk, since women often give birth without a 
skilled attendant. Lastly the gap between rural-urban care during pregnancy and 
childbirth will hopefully be reduced. The second area will be achieved by more 
women receiving antenatal care and other reproductive health measures that 
are lacking in developing areas. (UN MDG 2010.) 
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7 CONCLUSION 
Preeclampsia remains as a continuing problem worldwide (WHO 2007, 17-18). 
This is partly due to lack of adequate knowledge pregnant women have about 
the disorder (Oyira et al. 2009, 1.) Prioritization of universal patient education 
regarding preeclampsia is essential to prevent this disorder that continues to 
cause a high rate of maternal deaths globally (Souza et al. 2007, 1-6). Women 
who have had direct experience with preeclampsia should be mobilized to help 
educate the broader population about this disorder. Results from researches 
regarding direct experience with preeclampsia should help guide the furthering 
of education about this disorder. Two strategies need to be implanted. The first 
is to increase women’s awareness regarding preeclampsia. The second is to 
create an educated woman who can take responsibilities of her own health 
upon noticing signs and symptoms, so that she can seek preventive measures. 
The creation of webpages about preeclampsia will help to expand educative 
resources available to a larger population. 
Communication flaws between health professionals and pregnant women at risk 
of preeclampsia should be cleared. Health professionals should be updated with 
current information on preeclampsia so as to pass it to women at risk of PE. 
The information given to pregnant women should be to their level of 
understanding. Lastly, the information summarized here is available, in the form 
of webpages, to women and health care personnel to enable them to make 
more informed decisions about care when it comes to high risk pregnancy. 
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